Melincoff Gwen A
Insider CIK 1614890 · PLX Director · COLL Director · TBRA Director · SLNO Director · GANX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-04 | 17,000 | — | $0 | 17,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-04 | 8,500 | — | $0 | 8,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2026-09-03 | 2026-09-04 | 17,000 | — | $0 | 17,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2026-07-15 | 2026-07-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2025-09-03 | 2025-09-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2025-09-03 | 2025-09-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2025-06-24 | 2025-06-25 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2024-06-24 | 2024-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2024-05-16 | 2024-05-16 | 7,693 | — | $0 | 52,468 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2023-09-29 | 2023-10-03 | 61,676 | — | $0 | 61,676 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2023-06-23 | 2023-06-26 | 10,500 | — | $0 | 10,500 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2023-05-26 | 2023-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2023-05-25 | 2023-05-26 | 2,666 | — | $0 | 2,666 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2023-05-18 | 2023-05-19 | 9,792 | — | $0 | 44,775 | SEC↗ |
| GANX Gain Therapeutics, Inc. | A Award deriv | 2022-09-20 | 2022-09-22 | 10,500 | — | $0 | 10,500 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2022-09-07 | 2022-09-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2022-06-01 | 2022-10-14 | 2,666 | — | $0 | 2,666 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2022-05-19 | 2022-05-23 | 14,035 | — | $0 | 34,983 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2021-06-01 | 2021-06-04 | 31,862 | — | $0 | 31,862 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2021-05-20 | 2021-05-24 | 9,941 | — | $0 | 20,948 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2021-01-08 | 2021-01-12 | 40,000 | — | $0 | 81,887 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2020-05-20 | 2020-05-22 | 8,095 | — | $0 | 8,095 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2020-05-20 | 2020-05-22 | 4,047 | — | $0 | 11,007 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2020-05-18 | 2020-05-20 | 9,530 | — | $0 | 9,530 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2020-01-20 | 2020-01-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | P Buy | 2019-11-19 | 2019-11-20 | 10,000 | $1.54 | $15.4K | 10,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2019-06-10 | 2019-06-12 | 13,000 | — | $0 | 13,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2019-04-26 | 2019-04-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2019-04-25 | 2019-04-29 | 9,414 | — | $0 | 9,414 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2019-04-25 | 2019-04-29 | 4,707 | — | $0 | 6,960 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2018-05-24 | 2018-05-29 | 4,506 | — | $0 | 4,506 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award | 2018-05-24 | 2018-05-29 | 2,253 | — | $0 | 2,253 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | A Award deriv | 2017-08-09 | 2017-08-11 | 25,067 | — | $0 | 25,067 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 15,500 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 13,539 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | D To issuer deriv | 2016-11-01 | 2016-11-03 | 17,778 | — | $0 | 0 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2016-01-12 | 2016-01-14 | 17,778 | — | $0 | 17,778 | SEC↗ |
| TBRA Tobira Therapeutics, Inc. | A Award deriv | 2015-07-09 | 2015-07-13 | 15,500 | — | $0 | 15,500 | SEC↗ |
| TBRA Tibira Therapeutics, Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 13,539 | — | $0 | 13,539 | SEC↗ |